BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26822809)

  • 1. A novel role for the deubiquitinase USP1 in the control of centrosome duplication.
    Jung JK; Jang SW; Kim JM
    Cell Cycle; 2016; 15(4):584-92. PubMed ID: 26822809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis.
    Suizu F; Ryo A; Wulf G; Lim J; Lu KP
    Mol Cell Biol; 2006 Feb; 26(4):1463-79. PubMed ID: 16449657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability.
    Cheng X; Shen Z; Yang J; Lu SH; Cui Y
    J Biol Chem; 2008 Feb; 283(9):5888-98. PubMed ID: 18162463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATAD5 suppresses centrosome over-duplication by regulating UAF1 and ID1.
    Kim SJ; Wie M; Park SH; Kim TM; Park JH; Kim S; Myung K; Lee KY
    Cell Cycle; 2020 Aug; 19(15):1952-1968. PubMed ID: 32594826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of USP1 induces apoptosis via ID1/AKT pathway in B-cell acute lymphoblastic leukemia cells.
    Kuang X; Xiong J; Lu T; Wang W; Zhang Z; Wang J
    Int J Med Sci; 2021; 18(1):245-255. PubMed ID: 33390793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.
    Lingle WL; Lukasiewicz K; Salisbury JL
    Adv Exp Med Biol; 2005; 570():393-421. PubMed ID: 18727509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts.
    Iovino F; Lentini L; Amato A; Di Leonardo A
    Mol Cancer; 2006 Sep; 5():38. PubMed ID: 16987420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of USP1 autocleavage in DNA interstrand crosslink repair.
    Kim M; Kim JM
    FEBS Lett; 2016 Feb; 590(3):340-8. PubMed ID: 26783108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal centrosome amplification in the absence of p53.
    Fukasawa K; Choi T; Kuriyama R; Rulong S; Vande Woude GF
    Science; 1996 Mar; 271(5256):1744-7. PubMed ID: 8596939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of AMPKalpha1 Triggers Centrosome Amplification via PLK4 Upregulation in Mouse Embryonic Fibroblasts.
    Zhao Q; Coughlan KA; Zou MH; Song P
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the 'Fingers' subdomain of the deubiquitinase USP1 modulate its function and activity.
    Olazabal-Herrero A; García-Santisteban I; Rodríguez JA
    FEBS J; 2016 Mar; 283(5):929-46. PubMed ID: 26758085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function analysis of USP1: insights into the role of Ser313 phosphorylation site and the effect of cancer-associated mutations on autocleavage.
    Olazabal-Herrero A; García-Santisteban I; Rodríguez JA
    Mol Cancer; 2015 Feb; 14(1):33. PubMed ID: 25744535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of aspartic acid 199 in USP1 disrupts its deubiquitinating activity and impairs DNA repair.
    Jang SW; Kim JM
    FEBS Lett; 2021 Aug; 595(15):1997-2006. PubMed ID: 34128540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.
    Li JJ; Li SA
    Pharmacol Ther; 2006 Sep; 111(3):974-84. PubMed ID: 16603252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues.
    Cosenza MR; Krämer A
    Chromosome Res; 2016 Jan; 24(1):105-26. PubMed ID: 26645976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.
    Zhou H; Kuang J; Zhong L; Kuo WL; Gray JW; Sahin A; Brinkley BR; Sen S
    Nat Genet; 1998 Oct; 20(2):189-93. PubMed ID: 9771714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of tumor suppressor Kank1 induces centrosomal amplification via hyperactivation of RhoA.
    Suzuki JI; Roy BC; Ogaeri T; Kakinuma N; Kiyama R
    Exp Cell Res; 2017 Apr; 353(2):79-87. PubMed ID: 28284839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of centrosomes in cells and their potential contribution to carcinogenesis].
    Białkowska A; Koczorowska AM; Kluzek K
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():1050-68. PubMed ID: 25228514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells.
    Mistry H; Hsieh G; Buhrlage SJ; Huang M; Park E; Cuny GD; Galinsky I; Stone RM; Gray NS; D'Andrea AD; Parmar K
    Mol Cancer Ther; 2013 Dec; 12(12):2651-62. PubMed ID: 24130053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of USP1 deubiquitinase in the pathogenesis and therapy of cancer.
    Antonenko S; Zavelevich M; Telegeev G
    Acta Biochim Pol; 2023 Jun; 70(2):219-231. PubMed ID: 37331010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.